Ron Branning, BBA, MBA GXP Quality Systems, LLC

Ron Branning, Chief Executive Officer and co-founder of GXP Quality Systems, collaborates with the COO on the overall strategy for the company. He is the principal consultant for the transition from Clinical to Commercial (GMP, GDP) aspects of the consulting services, and has primary responsibility for management oversight and governance of deliverables to clients. With more than 50 years’ experience in the Bio/Pharmaceutical Industry, Ron brings a wealth of worldwide Quality experience in devices, drugs, biologics, and biotechnology and combination products in virtually all dosage forms. Ron’s career has been focused on resolution of significant quality issues and implementing Quality Systems that are designed to ensure compliance and rapid new product approval.

Ron began his career in 1968 with J&J, Quality Systems Compliance in 2007. He has served as Head of Corporate Quality for Genzyme, Gilead, Genentech, Aventis Behring, Somatogen and Serono. His other Quality management positions have been with Genetics Institute, Boehringer Ingelheim, GD Searle and Johnson and Johnson.

In addition, Ron has been a member of the ISPE International Leadership Forum, Scientific Advisory Board, Peking University MBA Program, Beijing China as well as President & board member of ISPE’s Boston Area Chapter & PDA Texas Chapter board member.